Coating compositions for bioactive agents

• US 20060083772A1
• Filed: 10/06/2005
• Published: 04/20/2006
• Est. Priority Date: 04/06/2004
• Status: Abandoned Application

• Current Assignee: Surmodics Incorporated
• Original Assignee: Surmodics Incorporated
• Inventors: Lawin, Laurie R., Finley, Michael J., DeWitt, David M.
• Application Number:
  US11/244,823
• Publication Number:
  US 20060083772A1
• Time in Patent Office: Days
• US Class Current: 424/426
• CPC Class Codes: A61L 2300/608 having two or more layers
• CPC Class Codes: A61L 2420/08 Coatings comprising two or more layers
• CPC Class Codes: A61L 29/085 Macromolecular materials
• CPC Class Codes: A61L 29/16 Biologically active materials, e.g. therapeutic substances A61L29/048 takes precedence
• CPC Class Codes: A61L 31/10 Macromolecular materials
• CPC Class Codes: A61L 31/16 Biologically active materials, e.g. therapeutic substances A61L31/047 takes precedence
• CPC Class Codes: C08L 33/06 of esters containing only carbon, hydrogen and oxygen, which oxygen atoms are present only as part of the carboxyl radical

Abstract

A coating composition and related method for use in applying a bioactive agent to a surface in a manner that will permit the bioactive agent to be released from the coating in vivo. The composition is particularly well suited for coating the surface of implantable medical device, such as a stent or catheter, in order to permit the device to release bioactive agent to the surrounding tissue over time. The composition includes a plurality of compatible polymers having different properties that can permit them to be combined together to provide an optimal combination of such properties as durability, biocompatibility, and release kinetics.

Claims

1. A composition for coating the surface of a medical device with a bioactive agent in a manner that permits the coated surface to release the bioactive agent over time when implanted in vivo, the composition comprising a bioactive agent in combination with a plurality of polymers, including a first polymer component and a second polymer component, and further comprising a topcoat in apposition to the composition, the topcoat including the polymer of the second polymer component in the composition and a topcoat bioactive agent.

2. The composition of claim 1, wherein the bioactive agent is distinguishable from the topcoat bioactive agent.

3. The composition of claim 1, wherein the first polymer component comprises at least one polymer selected from the group consisting of ethylene copolymers with other alkylenes, polybutenes, aromatic group-containing copolymers, epichlorohydrin-containing polymers, poly(alkylene-co-alkyl(meth)acrylates), and diolefin-derived, non-aromatic polymers and copolymers.

4. The composition of claim 1, wherein the second polymer component comprises a polymer selected from the group consisting of poly(alkyl(meth)acrylates) and poly(aromatic(meth)acrylates).

5. The composition of claim 1, further including the medical device, the medical device having a roughened surface to increase the adhesion of the coating composition to the medical device and/or alter the elution rate of the bioactive agent.

6. The composition of claim 1, further including an additional polymer.

7. A composition for coating the surface of a medical device with a bioactive agent in a manner that permits the coated surface to release the bioactive agent over time when implanted in vivo, the composition comprising a bioactive agent in combination with a plurality of polymers, including a first polymer component comprising at least one polymer selected from the group consisting of ethylene copolymers with other alkylenes, polybutenes, aromatic group-containing copolymers, epichlorohydrin-containing polymers, poly(alkylene-co-alkyl(meth)acrylates), and diolefin-derived, non-aromatic polymers and copolymers and a second polymer component comprising a polymer selected from the group consisting of poly(alkyl(meth)acrylates) and poly(aromatic(meth)acrylates), and further comprising a topcoat in apposition to the composition, the topcoat including the polymer of the second polymer component in the composition and a topcoat bioactive agent.

8. The composition of claim 7, wherein the bioactive agent is distinguishable from the topcoat bioactive agent.

9. The composition of claim 7, further including the medical device, the medical device having a roughened surface to increase the adhesion of the coating composition to the medical device and/or alter the elution rate of the bioactive agent.

10. A composition for coating the surface of a medical device with a bioactive agent in a manner that permits the coated surface to release the bioactive agent over time when implanted in vivo, the composition comprising a bioactive agent in combination with a plurality of polymers, including a first polymer component and a second polymer component, and further comprising a topcoat in apposition to the composition, the topcoat including a topcoat bioactive agent, the topcoat reducing the elution rate of a bioactive agent from a medical device surface.

11. The composition of claim 10, wherein the topcoat is relatively thin compared to the composition.

12. The composition of claim 10, wherein the topcoat reduces bioactive agent elution rates.

13. The composition of claim 10, wherein the topcoat weighs less than about five percent of the composition and reduces elution rates by more than about fifty percent for at least about twenty hours compared to compositions without topcoats.

14. The composition of claim 10, wherein the first polymer component comprises at least one polymer selected from the group consisting of ethylene copolymers with other alkylenes, polybutenes, aromatic group-containing copolymers, epichlorohydrin-containing polymers, poly(alkylene-co-alkyl(meth)acrylates), and diolefin-derived, non-aromatic polymers and copolymers

15. The composition of claim 10, wherein the second polymer component comprises a polymer selected from the group consisting of poly(alkyl(meth)acrylates) and poly(aromatic(meth)acrylates).

16. The composition of claim 10, further including the medical device, the medical device having a roughened surface to increase the adhesion of the coating composition to the medical device and/or alter the elution rate of the bioactive agent.

17. A composition for coating the surface of a medical device with a bioactive agent in a manner that permits the coated surface to release the bioactive agent over time when implanted in vivo, the composition comprising a bioactive agent in combination with a plurality of polymers, including a hydrophobic first polymer component and a hydrophobic second polymer component, and further comprising a hydrophilic topcoat.

18. The composition of claim 17, the hydrophilic topcoat comprising an agent selected from the group consisting of polyacrylamide(36%)co-methacrylic acid(MA)-(10%)co-methoxy PEG1000MA-(4%)co-BBA-APMA, photoheparin, and a photoderivatized coating agent.

19. The composition of claim 17, wherein the hydrophobic first polymer component comprises at least one polymer selected from the group consisting of ethylene copolymers with other alkylenes, polybutenes, aromatic group-containing copolymers, epichlorohydrin-containing polymers, poly(alkylene-co-alkyl(meth)acrylates), and diolefin-derived, non-aromatic polymers and copolymers.

20. The composition of claim 17, wherein the hydrophobic second polymer component comprises a polymer selected from the group consisting of poly(alkyl(meth)acrylates) and poly(aromatic(meth)acrylates).

21. A method of controlling the elution rate of one or more bioactive agents from a coated surface of a medical device comprising:

administering a bioactive agent coating including a composition comprising a bioactive agent in combination with a plurality of polymers, including a first polymer component and a second polymer component to a surface; and

administering a topcoat over the bioactive agent coating, the topcoat including one or more bioactive agents.

22. The method of controlling the elution rate of one or more bioactive agents from a coated surface of a medical device of claim 21 wherein the topcoat includes a one or more materials selected from the group consisting of a first polymer component, a second polymer component, parylene, photochemical materials, thermochemical materials and hydrophilic materials.

23. The method of controlling the elution rate of one or more bioactive agents from a coated surface of a medical device of claim 22 wherein the topcoat includes a second polymer component selected from one or more polyalkyl(meth)acrylates.

24. The method of controlling the elution rate of one or more bioactive agents from a coated surface of a medical device of claim 22 wherein the topcoat includes one or more photochemical or thermochemical materials selected from the group consisting of photo-heparin and photo-collagen.

25. The method of controlling the elution rate of one or more bioactive agents from a coated surface of a medical device of claim 22 wherein the topcoat includes a hydrophilic material selected from the group consisting of polyacrylamide(36%)co-methacrylic acid(MA)-(10%)co-methoxy PEG1000MA-(4%)co-BBA-APMA and photoheparin.

26. A combination including a medical device and a composition for coating the surface of the medical device with a bioactive agent in a manner that permits the coated surface to release the bioactive agent over time when implanted in vivo, the composition comprising a bioactive agent in combination with a plurality of polymers, including a first polymer component and a second polymer component, the medical device having a roughened surface to increase the adhesion of the coating composition to the medical device and/or alter the elution rate of the bioactive agent.

27. The combination of claim 26, wherein the first polymer component comprises at least one polymer selected from the group consisting of ethylene copolymers with other alkylenes, polybutenes, aromatic group-containing copolymers, epichlorohydrin-containing polymers, poly(alkylene-co-alkyl(meth)acrylates), and diolefin-derived, non-aromatic polymers and copolymers.

28. The combination of claim 26, wherein the second polymer component comprises a polymer selected from the group consisting of poly(alkyl(meth)acrylates) and poly(aromatic(meth)acrylates).

29. The combination of claim 26, wherein the extent of roughening ranges from about 2 μ

m to about 20 μ

m.

30. The combination of claim 26, wherein the medical device comprises an ocular coil.